Management of Respiratory Rate in Hypercapnia

Initial Assessment and Management

The British Thoracic Society recommends immediately measuring arterial blood gases to confirm PCO2 levels and assess pH to determine if respiratory acidosis is present in patients with known or suspected hypercapnia 1
Monitor respiratory rate carefully, as patients with respiratory rates >30 breaths/min may indicate respiratory distress and require urgent intervention 1
Target oxygen saturation of 88-92% in patients with risk factors for hypercapnic respiratory failure to avoid worsening hypercapnia, as recommended by the British Thoracic Society 1, 2

Increase respiratory rate to improve minute ventilation and CO2 clearance in patients with mild to moderate hypercapnia, as suggested by the American Thoracic Society 3
In spontaneously breathing patients, encourage deeper breathing at a rate of 15-20 breaths per minute, as recommended by the American Academy of Sleep Medicine 4
For patients on non-invasive ventilation (NIV), consider using the ST mode (spontaneous-timed) with a backup rate equal to or slightly less than the patient's spontaneous sleeping respiratory rate (minimum 10 breaths/min), as suggested by the American Academy of Sleep Medicine 4

For patients requiring mechanical ventilation, initially use assist-control mode (volume-cycled ventilation) to provide complete ventilatory support, as recommended by the European Society of Intensive Care Medicine 6
Adjust tidal volume based on ideal body weight (6-8 mL/kg) while monitoring plateau pressures to stay below 30 cmH2O, as suggested by the European Society of Intensive Care Medicine 6
Increase respiratory rate to maintain adequate minute ventilation and CO2 clearance, but be cautious of rates exceeding 30 breaths/min which may lead to air trapping, as recommended by the European Society of Intensive Care Medicine 6

Recheck blood gases after 30-60 minutes following any change in respiratory rate or oxygen therapy to assess effectiveness, as recommended by the British Thoracic Society 1, 2
Monitor for signs of respiratory muscle fatigue (paradoxical breathing, use of accessory muscles) which may indicate need for ventilatory support, as suggested by the American Academy of Sleep Medicine 4
Assess for adequate respiratory muscle rest during NIV, indicated by resolution of tachypnea and decreased inspiratory effort, as recommended by the American Academy of Sleep Medicine 4

For patients with COPD exacerbations, be vigilant for development of hypercapnic respiratory failure even if initial blood gases were satisfactory, as recommended by the British Thoracic Society 1
In patients with previous episodes of hypercapnic failure, start with low-concentration oxygen (24% Venturi mask at 2-3 L/min or nasal cannulae at 1-2 L/min), as suggested by the British Thoracic Society 7

Avoid excessive oxygen therapy in patients at risk for hypercapnic respiratory failure, as this can worsen respiratory acidosis, as recommended by the British Thoracic Society 1, 2
Never abruptly discontinue oxygen therapy in hypercapnic patients as this can cause life-threatening rebound hypoxemia, as recommended by the British Thoracic Society 1